CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C31504 | BRD-K91757634 | BRD-K91757634 | -- | -- | -- | Details |
C31505 | BRD-K91758467 | BRD-K91758467 | -- | -- | -- | Details |
C31506 | BRD-K91758890 | 4-HQN | PARP1 | PARP inhibitor | -- | Details |
C31507 | BRD-K91766181 | BRD-K91766181 | -- | -- | -- | Details |
C31508 | BRD-K91771673 | BRD-K91771673 | -- | -- | -- | Details |
C31509 | BRD-K91773518 | BRD-K91773518 | -- | -- | -- | Details |
C31510 | BRD-K91775327 | BRD-K91775327 | -- | -- | -- | Details |
C31511 | BRD-K91779437 | BRD-K91779437 | -- | -- | -- | Details |
C31512 | BRD-K91781484 | BRD-K91781484 | NFE2L2 | NRF2 activator | -- | Details |
C31513 | BRD-K91784140 | BRD-K91784140 | -- | -- | -- | Details |
C31514 | BRD-K91786278 | BRD-K91786278 | -- | -- | -- | Details |
C31515 | BRD-K91787616 | BRD-K91787616 | -- | -- | -- | Details |
C31516 | BRD-K91795767 | BRD-K91795767 | -- | -- | -- | Details |
C31517 | BRD-K91796483 | BRD-K91796483 | -- | -- | -- | Details |
C31518 | BRD-K91799761 | BRD-K91799761 | -- | -- | -- | Details |
C31519 | BRD-K91809691 | BRD-K91809691 | -- | -- | -- | Details |
C31520 | BRD-K91810283 | BRD-K91810283 | -- | -- | {1-[3-(4-methylphenoxy)propyl]-1H-benzimidazol-2-yl}methanol | Details |
C31521 | BRD-K91811806 | BRD-K91811806 | -- | -- | -- | Details |
C31522 | BRD-K91813753 | BRD-K91813753 | -- | -- | -- | Details |
C31523 | BRD-K91818252 | BRD-K91818252 | -- | -- | -- | Details |
C31524 | BRD-K91818277 | BRD-K91818277 | -- | -- | -- | Details |
C31525 | BRD-K91820608 | BRD-K91820608 | -- | -- | -- | Details |
C31526 | BRD-K91822704 | torcitabine | -- | -- | -- | Details |
C31527 | BRD-K91825936 | ZK-811752 | -- | -- | -- | Details |
C31528 | BRD-K91832210 | BRD-K91832210 | -- | -- | -- | Details |
C31529 | BRD-K91833864 | BRD-K91833864 | -- | -- | -- | Details |
C31530 | BRD-K91834385 | BRD-K91834385 | -- | -- | -- | Details |
C31531 | BRD-K91836330 | BRD-K91836330 | -- | -- | -- | Details |
C31532 | BRD-K91836367 | BRD-K91836367 | -- | -- | -- | Details |
C31533 | BRD-K91843292 | BRD-K91843292 | -- | -- | -- | Details |
C31534 | BRD-K91844626 | BRD-K91844626 | -- | -- | -- | Details |
C31535 | BRD-K91849632 | BRD-K91849632 | -- | -- | -- | Details |
C31536 | BRD-K91850687 | BRD-K91850687 | -- | -- | -- | Details |
C31537 | BRD-K91853144 | BRD-K91853144 | -- | -- | -- | Details |
C31538 | BRD-K91854399 | BRD-K91854399 | -- | -- | -- | Details |
C31539 | BRD-K91857575 | BRD-K91857575 | -- | -- | -- | Details |
C31540 | BRD-K91859707 | BRD-K91859707 | -- | -- | -- | Details |
C31541 | BRD-K91862102 | p-aminophenethylspiperone | -- | -- | -- | Details |
C31542 | BRD-K91863345 | MW-STK33-1B | -- | -- | -- | Details |
C31543 | BRD-K91866516 | BRD-K91866516 | -- | -- | -- | Details |
C31544 | BRD-K91868345 | BRD-K91868345 | -- | -- | -- | Details |
C31545 | BRD-K91876603 | BRD-K91876603 | -- | -- | -- | Details |
C31546 | BRD-K91879432 | BRD-K91879432 | -- | -- | -- | Details |
C31547 | BRD-K91880445 | BRD-K91880445 | -- | -- | -- | Details |
C31548 | BRD-K91885806 | BRD-K91885806 | -- | -- | -- | Details |
C31549 | BRD-K91892860 | BRD-K91892860 | -- | -- | -- | Details |
C31550 | BRD-K91895574 | BRD-K91895574 | -- | -- | -- | Details |
C31551 | BRD-K91897530 | BRD-K91897530 | -- | -- | -- | Details |
C31552 | BRD-K91898214 | BRD-K91898214 | -- | -- | -- | Details |
C31553 | BRD-K91899208 | BRD-K91899208 | -- | -- | -- | Details |
C31554 | BRD-K91900765 | VX-745 | MAPK14 | P38 MAPK inhibitor | -- | Details |
C31555 | BRD-K91904471 | SD-169 | MAPK14 | P38 MAPK inhibitor | -- | Details |
C31556 | BRD-K91905575 | BRD-K91905575 | -- | -- | -- | Details |
C31557 | BRD-K91913968 | BRD-K91913968 | -- | -- | -- | Details |
C31558 | BRD-K91917132 | BRD-K91917132 | -- | -- | -- | Details |
C31559 | BRD-K91922990 | BRD-K91922990 | -- | -- | -- | Details |
C31560 | BRD-K91923964 | BRD-K91923964 | -- | -- | -- | Details |
C31561 | BRD-K91924645 | BRD-K91924645 | -- | -- | -- | Details |
C31562 | BRD-K91937280 | BRD-K91937280 | -- | -- | -- | Details |
C31563 | BRD-K91937579 | KU-C104255 | -- | -- | -- | Details |
C31564 | BRD-K91938660 | memantine | GRIN1 | Glutamate receptor antagonist | -- | Details |
C31565 | BRD-K91944762 | BRD-K91944762 | -- | -- | N-[2-(2-Chloro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-4-methyl-benzenesulfonamide | Details |
C31566 | BRD-K91945291 | BRD-K91945291 | -- | -- | -- | Details |
C31567 | BRD-K91946056 | BRD-K91946056 | -- | -- | -- | Details |
C31568 | BRD-K91952416 | BRD-K91952416 | -- | -- | -- | Details |
C31569 | BRD-K91960538 | dimethylnitrosamine | -- | -- | -- | Details |
C31570 | BRD-K91962463 | BRD-K91962463 | -- | -- | -- | Details |
C31571 | BRD-K91966436 | daunorubicin | TOP2A | RNA synthesis inhibitor; Topoisomerase inhibitor | -- | Details |
C31572 | BRD-K91969329 | BRD-K91969329 | -- | -- | -- | Details |
C31573 | BRD-K91973560 | BRD-K91973560 | -- | -- | -- | Details |
C31574 | BRD-K91980109 | BRD-K91980109 | -- | -- | -- | Details |
C31575 | BRD-K91987625 | BRD-K91987625 | -- | -- | -- | Details |
C31576 | BRD-K91998226 | BRD-K91998226 | -- | -- | -- | Details |
C31577 | BRD-K92000256 | BRD-K92000256 | -- | -- | -- | Details |
C31578 | BRD-K92000912 | AM-251 | CNR1 | Cannabinoid receptor antagonist | -- | Details |
C31579 | BRD-K92008394 | BRD-K92008394 | -- | -- | -- | Details |
C31580 | BRD-K92009052 | BRD-K92009052 | -- | -- | -- | Details |
C31581 | BRD-K92011556 | BRD-K92011556 | -- | -- | -- | Details |
C31582 | BRD-K92012390 | BRD-K92012390 | -- | -- | -- | Details |
C31583 | BRD-K92012565 | BRD-K92012565 | -- | -- | -- | Details |
C31584 | BRD-K92014112 | BRD-K92014112 | -- | -- | -- | Details |
C31585 | BRD-K92014291 | BRD-K92014291 | -- | -- | -- | Details |
C31586 | BRD-K92015269 | GBR-12783 | -- | -- | -- | Details |
C31587 | BRD-K92018859 | BRD-K92018859 | -- | -- | -- | Details |
C31588 | BRD-K92020737 | BRD-K92020737 | -- | -- | -- | Details |
C31589 | BRD-K92022308 | BRD-K92022308 | -- | -- | -- | Details |
C31590 | BRD-K92022897 | BRD-K92022897 | -- | -- | -- | Details |
C31591 | BRD-K92023938 | BRD-K92023938 | -- | -- | -- | Details |
C31592 | BRD-K92028820 | BRD-K92028820 | -- | -- | -- | Details |
C31593 | BRD-K92033419 | BRD-K92033419 | -- | -- | -- | Details |
C31594 | BRD-K92036763 | BRD-K92036763 | -- | -- | -- | Details |
C31595 | BRD-K92038420 | BRD-K92038420 | -- | -- | -- | Details |
C31596 | BRD-K92041145 | O6-benzylguanine | -- | -- | O-6-BENZYLGUANINE | Details |
C31597 | BRD-K92042497 | mestranol | ESR1 | Estrogen receptor agonist | -- | Details |
C31598 | BRD-K92043077 | BRD-K92043077 | -- | -- | -- | Details |
C31599 | BRD-K92047490 | BRD-K92047490 | -- | -- | -- | Details |
C31600 | BRD-K92048968 | BRD-K92048968 | -- | -- | -- | Details |
C31601 | BRD-K92049597 | triamterene | SCNN1A; SCNN1B; SCNN1G | Sodium channel blocker | -- | Details |
C31602 | BRD-K92059157 | BRD-K92059157 | -- | -- | -- | Details |
C31603 | BRD-K92061784 | BRD-K92061784 | -- | -- | -- | Details |